Your browser doesn't support javascript.
loading
Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.
Hope, William; Stone, Neil R H; Johnson, Adam; McEntee, Laura; Farrington, Nicola; Santoro-Castelazo, Anahi; Liu, Xuan; Lucaci, Anita; Hughes, Margaret; Oliver, Jason D; Giamberardino, Charles; Mfinanga, Sayoki; Harrison, Thomas S; Perfect, John R; Bicanic, Tihana.
Afiliação
  • Hope W; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom william.hope@liverpool.ac.uk.
  • Stone NRH; Royal Liverpool Broadgreen University Hospital Trust, Liverpool Health Partners, Liverpool, United Kingdom.
  • Johnson A; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom.
  • McEntee L; Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.
  • Farrington N; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom.
  • Santoro-Castelazo A; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom.
  • Liu X; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom.
  • Lucaci A; Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom.
  • Hughes M; Centre for Genomics Research, University of Liverpool, Liverpool, United Kingdom.
  • Oliver JD; Centre for Genomics Research, University of Liverpool, Liverpool, United Kingdom.
  • Giamberardino C; Centre for Genomics Research, University of Liverpool, Liverpool, United Kingdom.
  • Mfinanga S; F2G Ltd., Eccles, United Kingdom.
  • Harrison TS; Division of Infectious Diseases and International Health, Duke University School of Medicine, Durham, North Carolina, USA.
  • Perfect JR; National Institute of Medical Research, Dar es Salaam, Tanzania.
  • Bicanic T; Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.
mBio ; 10(6)2019 12 03.
Article em En | MEDLINE | ID: mdl-31796539
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fluconazol / Meningite Criptocócica / Farmacorresistência Fúngica / Antifúngicos Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: MBio Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fluconazol / Meningite Criptocócica / Farmacorresistência Fúngica / Antifúngicos Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: MBio Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos